1. Home
  2. VRT vs VRTX Comparison

VRT vs VRTX Comparison

Compare VRT & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertiv Holdings LLC

VRT

Vertiv Holdings LLC

HOLD

Current Price

$300.55

Market Cap

142.1B

Sector

Technology

ML Signal

HOLD

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

HOLD

Current Price

$446.83

Market Cap

115.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRT
VRTX
Founded
N/A
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
EDP Services
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
142.1B
115.7B
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
VRT
VRTX
Price
$300.55
$446.83
Analyst Decision
Buy
Buy
Analyst Count
20
29
Target Price
$269.44
$539.69
AVG Volume (30 Days)
4.8M
1.1M
Earning Date
04-22-2026
05-04-2026
Dividend Yield
0.08%
N/A
EPS Growth
166.41
836.54
EPS
0.99
4.02
Revenue
N/A
$2,488,652,000.00
Revenue This Year
$34.04
$10.79
Revenue Next Year
$23.82
$10.47
P/E Ratio
$328.01
$110.02
Revenue Growth
N/A
46.20
52 Week Low
$107.38
$362.50
52 Week High
$379.94
$509.98

Technical Indicators

Market Signals
Indicator
VRT
VRTX
Relative Strength Index (RSI) 38.80 56.43
Support Level $293.88 $429.02
Resistance Level $379.94 $461.66
Average True Range (ATR) 17.51 10.08
MACD -4.37 0.78
Stochastic Oscillator 4.00 83.11

Price Performance

Historical Comparison
VRT
VRTX

About VRT Vertiv Holdings LLC

Vertiv has roots tracing back to 1946 when its founder, Ralph Liebert, developed an air-cooling system for mainframe data rooms. As computers started making their way into commercial applications in 1965, Liebert developed one of the first computer room air conditioning, or CRAC, units, enabling the precise control of temperature and humidity. The firm has slowly expanded its data center portfolio through internal product development and the acquisition of thermal and power management products like condensers, busways, and switches. Vertiv has global operations today; its products can be found in data centers in most regions throughout the world.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: